DYNAMIC decision-making.

The phase 2 DYNAMIC trial demonstrates that patients with resected stage II colon cancer randomized to post-surgery circulating tumor DNA-determined adjuvant chemo versus standard path-determined adjuvant chemo had nearly half the rate of chemo recommendation (15% v 28%) with no detriment in outcomes. | Tie, N Engl J Med 2022